Bionano Genomics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. 

CEO
Albert A. Luderer
CEOAlbert A. Luderer
Employees
97
Employees97
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2003
Founded2003
Employees
97
Employees97

BNGO Key Statistics

Market cap
13.25M
Market cap13.25M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
Dividend yield
Average volume
189.22K
Average volume189.22K
High today
$1.29
High today$1.29
Low today
$1.19
Low today$1.19
Open price
$1.28
Open price$1.28
Volume
287.91K
Volume287.91K
52 Week high
$5.50
52 Week high$5.50
52 Week low
$1.06
52 Week low$1.06

Stock Snapshot

As of today, Bionano Genomics(BNGO) shares are valued at $1.22. The company's market cap stands at 13.25M, with a P/E ratio of -0.23.

As of 2026-05-14, Bionano Genomics(BNGO) stock has fluctuated between $1.19 and $1.29. The current price stands at $1.22, placing the stock +2.5% above today's low and -5.4% off the high.

Bionano Genomics(BNGO) shares are trading with a volume of 287.91K, against a daily average of 189.22K.

During the past year, Bionano Genomics(BNGO) stock moved between $1.06 at its lowest and $5.50 at its peak.

During the past year, Bionano Genomics(BNGO) stock moved between $1.06 at its lowest and $5.50 at its peak.

BNGO News

TipRanks 2h
Bionano Genomics Earnings Call: Growth Amid Cash Burn

Bionano Genomics ((BNGO)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and po...

TipRanks 5h
BioNano Genomics Stockholders Approve 2026 Annual Meeting Proposals

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Seeking Alpha 1d
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve

Earnings Call Insights Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve May 13, 2026, 7:01 PM ET Bionano Genomics, Inc...

Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve

People also own

Based on the portfolios of people who own BNGO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.